NCT07398456Not yet recruiting
Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
The goal of this prospective implementation study is to understand the impact of a blood-based screening test (BBST) for colorectal cancer (CRC) on patient acceptability of and adherence to CRC screening as well as the rate of follow-up BBST in those with negative BBST at a 1-year interval. Additional aims include assessing the impact of digital patient navigation intervention on the rate of follow-up colonoscopy in individuals with positive BBST. Patients will be randomized into the non-intervention arm or the intervention with an app arm.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 5500 (estimated)
- First submitted
- 4 Feb 2026
- Start date
- 1 Nov 2026
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Baylor Research Institute
- Diseases
- Colorectal cancer
- NCT number
- NCT07398456
What you commit to
- Study type: Interventional
- Planned participants: 5500
- From 1 Nov 2026 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with a previous abnormal colonoscopy finding who are due for surveillance.
Other illness
- Patients with a personal history of CRC
- Patients with a known high-risk family history of CRC precluding the patient from being average risk
- Patients with known diagnosis of inflammatory bowel disease or history of polyps
- Patients with any known medical condition which, in the opinion of the investigator, should preclude enrollment into the study
Other
- Patients who are currently symptomatic for CRC such as: blood in the stool
- Have a recorded up to date CRC screening in the EMR (within 1 year for FIT, 3 years for mt-sDNA, 10 years for colonoscopy)
Who the study is looking for
- patients aged 45-84 years of age
- Considered by health-care providers to be "average risk" for CRC as determined by USPSTF guidelines
- If a patient opts for BBST, they are able and willing to provide blood samples per protocol
- Ability to understand and the willingness to participate in the study
- Must have been seen in HTPN clinic within the past 24 months from study activation
- Must have active MyBSW app portal account and/or establish account during study recruitment
Age in the registry: 45 years to 84 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Baylor University Medical Center, Baylor Charles A Sammons Cancer Center Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.